Evidence map›Paper›PMID 37389042›Full record

ArticleHeliyon2023

Effects of single-use alfentanil versus propofol on cognitive functions after colonoscopy: A randomized controlled trial.

Xiwen Zhu, Xuehan Chen, Xuemei Zheng, Hongyao Lyu, Jie Chen, Ai Yan, Qi Liu, Shiqi Li, Yamei Zhang, Ting Wang and 2 more

Abstract read
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. The median Effective Dose (EDBMC anesthesiology · 2025
    Trial
  4. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Xiwen ZhuDepartment of Anesthesiology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Xuehan ChenDepartment of Anesthesiology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Xuemei ZhengDepartment of Preventive Medicine, West China School of Public Health, Sichuan University, Chengdu, Sichuan, China.
Hongyao LyuDepartment of Preventive Medicine, West China School of Public Health, Sichuan University, Chengdu, Sichuan, China.
Jie ChenDepartment of Anesthesiology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Ai YanDepartment of Anesthesiology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Qi LiuDepartment of Anesthesiology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Shiqi LiDepartment of Anesthesiology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Yamei ZhangDepartment of Anesthesiology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Ting WangDepartment of Psychology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Guangyou DuanDepartment of Anesthesiology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
He HuangDepartment of Anesthesiology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Colonoscopy is often accompanied by short-term postoperative cognitive decline. We aimed to explore whether single-use alfentanil for patients undergoing elective colonoscopy could reduce cognitive impairment at discharge compared with propofol. Patients and methods: 172 adult patients undergoing elective colonoscopy were randomized to receive intravenous propofol at 2 mg/kg (group P) or alfentanil at 10 μg/kg (group A); 40 healthy volunteers were included in the blank group. Cognitive function was considered the primary outcome and was measured using five neuropsychological tests before sedation and discharge. The z-score method was used to determine cognitive dysfunction according to z-score >1.96 in two types of neuropsychological tests. Other outcomes included discharge time, vital signs, associated adverse events during colonoscopy, and the satisfaction level of patients and endoscopic physicians. Results: 164 patients (78 in group A and 86 in group P) completed the study protocol. At discharge, the incidence of cognitive dysfunction in group P was 23% and was significantly lower in the alfentanil group (2.5%), with a relative risk of 0.11 (95% confidence interval: 0.03-0.46, P < 0.001). The incidence of hypotension in group A was lower than that in group P (3.8% vs 22.1%, relative risk = 0.17 [95% confidence interval: 0.05-0.46, P = 0.001]), and the discharge time in group A was shorter than that in group P (5 [(Rutter and et al., 2016; Zhang and et al., 2013; Hirsh and et al., 2006; Zhou and et al., 2021; Singh and et al., 2008; Ko and et al., 2010; Sargin et al., 2019) 3-93-9 vs 13 [(Ekmekci and et al., 2017; Eberl and et al., 2012; Eberl and et al., 2014; N'Kaoua and et al., 2002; Chung et al., 1995; Berger and et al., 2019; Quan and et al., 2019; Deng and et al., 2021; Gualtieri and Johnson, 2006) 10-1810-18 min, P < 0.001). Conclusion: For patients undergoing colonoscopy, single-use alfentanil causes less damage to postoperative cognitive function, less risk of hypotension, and shorter discharge time than propofol.

Indexed as

AlfentanilCognitive functionColonoscopyPropofol

Identifiers

PMID37389042
PMCPMC10300329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.